Astec Lifesciences opened lower at ₹730.00, compared with its previous close of ₹730.85. During today's session, the stock has traded between ₹705.60 and ₹730.00, with an average traded price of ₹717.91. It is currently showing a sideways intraday trend.
An investment of ₹10,000 made 5 years ago in Astec Lifesciences is now worth
₹ 5,656.00
resulting in a loss of
₹ 4,344.00 (43.44%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
-5.45 (-0.75%)
Day High
₹730.00
Day Low
₹705.60
Day Open
₹730.00
Prev Close
₹730.85
Volume
38,847
Value Traded
₹2.79 Cr
1W Return
1.78%
1M Return
3.66%
3M Return
5.25%
6M Return
10.08%
1Y Return
-5.27%
Market Cap (₹ Cr.)
1,616
PE Ratio
-24.40
PB Ratio
4.15
Dividend Yield
0.21%
ROE
-20.69%
ROCE
-10.51%
Book Value (₹)
175.29
Face Value (₹)
10.00
EPS (TTM)
-8.40
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
1.78%
6 Week
-
1 Month
3.66%
3 Month
5.25%
9 Month
13.73%
Astec LifeSciences reports ₹18.7 crore consolidated net loss in Q1FY27
Astec LifeSciences Limited reported a consolidated net loss of ₹18.7 crore for Q1FY27, a significant improvement from the ₹33.0 crore loss in Q1FY26. Consolidated revenue fell 8% to ₹84.3 crore, primarily due to a sharp decline in Contract Manufacturing revenues, although the Enterprise segment saw strong growth. The company's financial health improved with a reduced debt-to-equity ratio of 0.99.
2mo agoAstec LifeSciences shareholders approve FY26 accounts, re-appoint director
Astec LifeSciences shareholders approved FY26 consolidated financials, re-appointed Mr. Ashok V. Hiremath, and ratified cost auditor remuneration at its 32nd AGM on July 31, 2026.
2mo agoAstec LifeSciences schedules 32nd AGM for July 31, 2026
Astec LifeSciences Limited has announced the schedule for its 32nd Annual General Meeting (AGM) to be held on July 31, 2026, via video conferencing. The agenda includes the adoption of financial statements for FY 2025-26 and the re-appointment of a director. Remote e-voting commences on July 26, 2026, and the company has also notified shareholders regarding the transfer of unclaimed dividends to the IEPF.
3mo agoAstec LifeSciences passes resolutions for director appointments and RPTs
Astec LifeSciences Limited secured shareholder approval for the appointment of four directors and related party transactions for the financial year 2026-27 through a postal ballot process that concluded on July 4, 2026. The resolutions included the appointment of Mr. Vishal Sharma and Mr. Burjis N. Godrej as Non-Executive, Non-Independent Directors, Mr. Arijit Mukherjee as Director and Executive Director, and Mr. Mathew Eipe as Independent Director. Shareholders also approved related party transactions with Godrej Agrovet Limited and Godrej Industries Limited, which exceeded the materiality threshold under SEBI regulations.
3mo agoAstec Lifesciences to hold 32nd AGM on July 31, 2026
Astec Lifesciences Limited has scheduled its 32nd Annual General Meeting for July 31, 2026, via Video Conferencing. Remote e-voting is open from July 26 to July 30, 2026, for shareholders registered as of July 24, 2026.
3mo agoGodrej Agrovet confirms no encumbrance on Astec shares in FY26
Godrej Agrovet Limited and its promoter group confirmed no encumbrance on Astec LifeSciences shares for FY26, complying with SEBI regulations.
3mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹524.70 | +1.91% | ₹44,293.56 | 18.67 | -22.99% | |
| ₹2,130.00 | -0.07% | ₹32,315.96 | 27.65 | -40.25% | |
| ₹414.25 | -0.52% | ₹20,677.11 | 35.84 | -21.51% | |
| ₹3,592.40 | +1.51% | ₹16,145.00 | 21.74 | -28.25% | |
| ₹721.25 | -0.88% | ₹6,507.15 | 10.48 | -12.04% | |
| ₹200.05 | -0.03% | ₹3,890.35 | 31.33 | -33.88% | |
| ₹866.70 | +1.70% | ₹3,863.60 | 12.82 | -41.37% | |
| ₹128.12 | -2.99% | ₹3,001.13 | 249.15 | -35.34% | |
| ₹221.66 | +0.52% | ₹2,874.24 | 104.93 | -12.06% | |
| ₹476.65 | -0.44% | ₹2,217.32 | 22.60 | +33.80% | |
| ₹580.90 | +1.39% | ₹1,690.29 | 13.30 | -21.76% | |
| ₹989.30 | +1.93% | ₹1,644.32 | 11.27 | -59.39% |
An investment of ₹10,000 made 5 years ago in Astec Lifesciences is now worth
₹ 5,656.00
resulting in a loss of
₹ 4,344.00 (43.44%)
Note: Past profits do not guarantee future returns.
